Physician

Adriana Guigova, DO

According to 2025 Medicare claims, Adriana Guigova, DO (NPI: 1891094447) practices hematology/oncology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Suffolk, NY. This provider's primary affiliated billing organization is NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (NPI: 1396794574; TIN: 112419534) and primary practice location at 11776-0001. Guigova is affiliated with the ilumed, LLC (ACO ID: D0005) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Guigova's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,529 traditional Medicare patients, billed 289,958 HCPCS/CPT codes, and received $4,156,586 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 2,060 prescription claims across 296 beneficiaries totaling $6,494,613 in drug costs, led by Ibrance (Palbociclib). DME data shows 39 claims. Open Payments data shows 1 records totaling $129. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $261,168 to $4,156,586. Similarly, Part D prescription costs have moved sharply higher in recent years, from $9,195 to $6,494,613. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	337	16,732	$261,168
2018	1,717	205,733	$3,218,751
2019	2,090	293,535	$3,770,277
2020	1,905	330,674	$3,803,607
2021	1,852	337,266	$3,931,136
2022	1,846	344,087	$4,493,896
2023	2,089	254,132	$3,387,512
2024	2,529	289,958	$4,156,586

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	21	$9,195
2017	33	97	$59,908
2018	124	493	$331,156
2019	147	873	$972,594
2020	171	1,037	$906,775
2021	177	1,035	$1,570,445
2022	212	1,378	$2,737,702
2023	247	1,610	$4,247,610
2024	296	2,060	$6,494,613

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	37	63	$9,263
2019	44	60	$6,476
2020	80	155	$11,996
2021	N/R	54	$3,765
2022	N/R	92	$3,084
2023	N/R	65	$7,308
2024	N/R	39	$1,211

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	1,684	4,060	$10
36415	Insertion of needle into vein for collection of blood sample	1,874	4,808	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	1,786	4,799	$8
83735	Magnesium level	1,460	3,698	$7
84100	Phosphate level	1,496	3,761	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	38	1,064	$566,047
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	61	1,708	$418,086
Darzalex Faspro	Daratumumab-Hyaluronidase-Fihj	37	1,048	$405,370
Reblozyl	Luspatercept-Aamt	11	249	$357,127
Aranesp	Darbepoetin Alfa In Polysorbat	130	2,943	$352,885

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	20	$854
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	19	$358

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$129	Intera Oncology, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adriana Guigova, DO?

Tedicare shows public-source Medicare data for Adriana Guigova, DO (NPI 1891094447), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adriana Guigova, DO have ACO affiliation data?

Adriana Guigova, DO is shown with ACO affiliation data for ilumed, LLC (REACH, ACO ID D0005) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Adriana Guigova, DO?

Adriana Guigova, DO is linked to NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (billing NPI 1396794574) in the available physician profile data.

Does Adriana Guigova, DO have Open Payments data?

Adriana Guigova, DO has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.